Pharmala Biotech Stock Quote MDMA - Stock Price, News, Charts, Message Board, Trades

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
Canada
CSE
Pharmala Biotech Holdings Inc (MDMA) Quote

Pharmala Biotech Holdings Inc (MDMA)

0.25

0.01

(4.17%)

Closed December 26 4:00PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

0.25

Bid

0.225

Ask

0.25

Volume

43,062

0.22 Day's Range 0.25

0.065 52 Week Range 0.35

Previous Close

0.24

Open

0.25

Last Trade

Last Trade Time

Average Volume (3m)

474,638

Financial Volume

-

VWAP

-

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.02	8.69565217391	0.23	0.265	0.22	116079	0.23622748	CS
4	-0.07	-21.875	0.32	0.33	0.195	350684	0.27455679	CS
12	0.17	212.5	0.08	0.34	0.075	474638	0.23532999	CS
26	0.125	100	0.125	0.34	0.065	318824	0.19196593	CS
52	0.095	61.2903225806	0.155	0.35	0.065	409719	0.19917249	CS
156	-0.19	-43.1818181818	0.44	0.54	0.02	570535	0.19080892	CS
260	-0.19	-43.1818181818	0.44	0.54	0.02	570535	0.19080892	CS

MDMA - Frequently Asked Questions (FAQ)

What is the current Pharmala Biotech share price?

The current share price of Pharmala Biotech is $ 0.25

What is the 1 year trading range for Pharmala Biotech share price?

Pharmala Biotech has traded in the range of $ 0.065 to $ 0.35 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CNTRCENTR Brands Corp	$ 0.15 (114.29%)	31.1k
BEEBee Vectoring Technologies International Inc	$ 0.01 (100.00%)	108.8k
AWRAurwest Resources Corporation	$ 0.01 (100.00%)	20k
WINCommon Stock	$ 0.015 (50.00%)	2.6k
RXMRockex Mining Corporation	$ 0.015 (50.00%)	1.73k
HROHero Innovation Group Inc	$ 0.005 (-66.67%)	100k
NXU.XNexco Resources Inc	$ 0.005 (-50.00%)	4k
PUMPStock Trend Capital Inc	$ 0.005 (-50.00%)	193.1k
WBIOWPD Pharmaceuticals Inc	$ 0.01 (-50.00%)	119k
AUMCAuric Minerals Corp	$ 1.72 (-43.23%)	566.38k
QIMCQuebec Innovative Materials Corp	$ 0.08 (-11.11%)	2.63M
SOLSOL Global Investments Corp	$ 0.38 (4.11%)	976.71k
NUENU E Power Corp	$ 0.35 (7.69%)	923.5k
IDKThreeD Capital Inc	$ 0.165 (-10.81%)	854.58k
SPODSpod Lithium Corp	$ 0.03 (-14.29%)	822.58k

lolroflmao

lolroflmao 1 month ago

PharmAla Reaches Agreement In Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License

https://pharmala.ca/media/2024/11/pharmala-reaches-agreement-in-principle-to-supply-mdma-to-clinical-trial-in-exchange-for-full-data-license

lolroflmao

lolroflmao 2 months ago

News: PharmAla to supply LaNeo MDMA for Clinical Trial at Yale

https://pharmala.ca/media/2024/11/pharmala-to-supply-laneo-mdma-for-clinical-trial-at-yale

lolroflmao

lolroflmao 2 months ago

PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA Press Release | 10/21/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Mt-Sinai-Hospital-with-LaNeo-MDMA?id=456329

lolroflmao

lolroflmao 2 months ago

PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA Press Release | 10/08/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-the-University-of-Texas-San-Antonio-with-novel-dosage-form-of-LaNeo-MDMA?id=455196

lolroflmao

lolroflmao 2 months ago

PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMAPress Release | 10/02/2024
https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Harvard-Medical-Schools-Maclean-Hospital-with-LaNeo-MDMA?id=454666

lolroflmao

lolroflmao 2 months ago

PharmAla to supply Johns Hopkins Medicine for Clinical TrialPress Release | 09/11/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Johns-Hopkins-Medicine-for-Clinical-Trial?id=452770

Dewayne18

Dewayne18 2 years ago

$MDMA New Short Call: Shorts in at 30 cents today. Stay tuned tomorrow for details of its pending doom. Last call 34% in less than 2 days.

Dewayne18

Dewayne18 2 years ago

$MDMA SHORT ALERT!!!

Company up on lousy $50,000 deal.... Shorts in at 38 cents CDN.

Quick 30%

Act Now!!!

Dewayne18

Dewayne18 2 years ago

$MDMA is looking like the perfect short. The SP is racing up and the company only has 700K left with shares doubling up in the past 12 months. Over the past 12 months cash went down by 1.2 million.

Forcealpine

Forcealpine 3 years ago

It looks like this IPO has gone similarly to all psych companies have. The industry needs a massive correction, but that cannot happen until government stop obsessing over vaccines and start promoting alternative solutions to the gigantic mental health crisis ongoing and perpetuating daily while being ignored. MDMA looks promising and I'll be keeping a very close eye on its news and resulting share price.

Pharmala Biotech

Delayed Upgrade Clock